1-6 of 6
Authors: Erik A Imel
Save search
Sort by
Journal Article

Real-World Clinical and Healthcare Resource Burden Among Burosumab-Naïve Patients With Familial Hypophosphatemia

PDF
Erik A Imel and others
Journal of the Endocrine Society, Volume 8, Issue 12, December 2024, bvae185, https://doi.org/10.1210/jendso/bvae185
Published: 24 October 2024
Journal Article

12605 Two Systematic Reviews Of Treatment Efficacy On Patient Important Outcomes In Children X-linked Hypophosphatemia

PDF
Dalal S Ali and others
Journal of the Endocrine Society, Volume 8, Issue Supplement_1, October-November 2024, bvae163.528, https://doi.org/10.1210/jendso/bvae163.528
Published: 05 October 2024
Journal Article

Healthcare Transition Preparation in X-Linked Hypophosphatemia

PDF
Kathryn Dahir and others
Journal of the Endocrine Society, Volume 5, Issue Supplement_1, April-May 2021, Pages A261–A262, https://doi.org/10.1210/jendso/bvab048.531
Published: 03 May 2021
Journal Article

SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH)

PDF
Erik A Imel and others
Journal of the Endocrine Society, Volume 4, Issue Supplement_1, April-May 2020, SUN-356, https://doi.org/10.1210/jendso/bvaa046.196
Published: 08 May 2020
Journal Article

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

PDF
Alison Skrinar and others
Journal of the Endocrine Society, Volume 3, Issue 7, July 2019, Pages 1321–1334, https://doi.org/10.1210/js.2018-00365
Published: 07 May 2019
Journal Article

Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis

PDF
Melissa J Schoelwer and others
Journal of the Endocrine Society, Volume 1, Issue 9, 1 September 2017, Pages 1160–1167, https://doi.org/10.1210/js.2017-00145
Published: 01 August 2017